APA (7th ed.) Citation

ALP, C., AS, G., A, B., D, M., C, V., G, T., . . . R, M. (2024). Long-term efficacy and safety of tailored immunosuppressive therapy in immune-mediated biopsy-proven myocarditis: A propensity-weighted study. European journal of heart failure, 26(5), 1175. https://doi.org/10.1002/ejhf.3220

Chicago Style (17th ed.) Citation

ALP, Caforio, et al. "Long-term Efficacy and Safety of Tailored Immunosuppressive Therapy in Immune-mediated Biopsy-proven Myocarditis: A Propensity-weighted Study." European Journal of Heart Failure 26, no. 5 (2024): 1175. https://doi.org/10.1002/ejhf.3220.

MLA (9th ed.) Citation

ALP, Caforio, et al. "Long-term Efficacy and Safety of Tailored Immunosuppressive Therapy in Immune-mediated Biopsy-proven Myocarditis: A Propensity-weighted Study." European Journal of Heart Failure, vol. 26, no. 5, 2024, p. 1175, https://doi.org/10.1002/ejhf.3220.